Laskers reward telomerase work

Announced today: The linkurl:2006 Lasker Award;http://www.laskerfoundation.org/ for Basic Medical Research is shared by Elizabeth Blackburn of the University of California, San Francisco, Carol Greider at Johns Hopkins University, and Jack Szostak of Harvard Medical School for their research on telomerase, the enzyme responsible for maintaining the length of linear chromosomes. In addition, Joseph Gall of the Carnegie Institution is being honored for his lifetime of discovery and innovation as

By | September 16, 2006

Announced today: The linkurl:2006 Lasker Award;http://www.laskerfoundation.org/ for Basic Medical Research is shared by Elizabeth Blackburn of the University of California, San Francisco, Carol Greider at Johns Hopkins University, and Jack Szostak of Harvard Medical School for their research on telomerase, the enzyme responsible for maintaining the length of linear chromosomes. In addition, Joseph Gall of the Carnegie Institution is being honored for his lifetime of discovery and innovation as a founder of modern cell biology, an inventor of in situ hybridization and an early champion of women in science. The foundation awards Gall the biannual Lasker Award for Special Achievement in Medical Science. The Award for Clinical Medical Research goes to University of Pennsylvania psychiatrist Aaron Beck, creator of the Beck Depression Inventory. For more detailed coverage, including interviews with all of the winners, check our homepage on Monday, September 18, and our podcast on Wednesday, September 20.

Popular Now

  1. UC Berkeley Receives CRISPR Patent in Europe
    Daily News UC Berkeley Receives CRISPR Patent in Europe

    The European Patent Office will grant patent rights over the use of CRISPR in all cell types to a University of California team, contrasting with a recent decision in the U.S.

  2. DNA Replication Errors Contribute to Cancer Risk
  3. Should Healthy People Have Their Exomes Sequenced?
    Daily News Should Healthy People Have Their Exomes Sequenced?

    With its announced launch of a whole-exome sequencing service for apparently healthy individuals, Ambry Genetics is the latest company to enter this growing market. But whether these services are useful for most people remains up for debate.  

  4. Rethinking a Cancer Drug Target
    Daily News Rethinking a Cancer Drug Target

    The results of a CRISPR-Cas9 study suggest that MELK—a protein thought to play a critical role in cancer—is not necessary for cancer cell survival.

Business Birmingham